Wednesday, May 14, 2025
HomeIndustriesHealthcare

Healthcare

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of the BRIGHT Phase III Clinical Trial Evaluating PRX-102 for the Treatment of Fabry...

Protalix BioTherapeutics, Inc. a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell‑based...

Ionis Announces Publication of Positive Phase 2 Data for Donidalorsen in New England Journal of Medicine

Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapies, announced the publication of positive Phase 2 data for donidalorsen (formerly IONIS-PKK-LRx) in the New England...

Institute for Supply Management Launches Advance™ Digital Skills Assessment Platform

Institute for Supply Management® (ISM®), has launched their patent-pending Advance™ Digital Platform that delivers online talent capability and organizational maturity assessments. The talent assessments...

ACCC Releases New Resources to Support Quality Care Delivery for Patients with Ovarian Cancer

The Association of Community Cancer Centers (ACCC) is pleased to announce a new suite of quality-directed resources for cancer programs, providers, and other stakeholders...

Biocom California Purchasing Group Announces LeggUP as New Professional Development Partner

Biocom California Purchasing Group, the group purchasing organization serving California's largest life science membership association, announced a new partnership with LeggUP – a professional...
0FansLike
0FollowersFollow
spot_img

Hot Topics